Project description
Training for green and digital pharmaceutical manufacturing
The European pharmaceutical industry is facing a significant challenge in greening and digitalising its manufacturing processes. A shortage of trained engineers and scientists hampers progress in this area. In this context, the EU-funded GreenDigiPharma project will produce a cohort of 10 highly skilled and trained PhD graduates who will spearhead the green and digital transformation of pharmaceutical manufacturing in both academic and industrial settings. The project will focus on pressing issues in sustainable manufacturing and explore greener methods for producing pharmaceutical products, incorporating innovative technologies such as heterogeneous nanocatalysts and biocatalysis, novel purification techniques and digitalisation tools. The GreenDigiPharma programme will also provide the early stage researchers with scientific and transferable knowledge on intellectual property rights, entrepreneurship, data management and innovation.
Objective
Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes.
This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments. The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.
Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.
Fields of science
- natural scienceschemical sciencesorganic chemistry
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyindustrial biotechnologybioprocessing technologies
- engineering and technologychemical engineeringchemical process engineering
- natural scienceschemical sciencescatalysisbiocatalysis
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinator
20133 Milano
Italy
See on map
Participants (6)
14005 Cordoba
See on map
1012WX Amsterdam
See on map
70121 Bari
See on map
1000 Ljubljana
See on map
9000 Gent
See on map
2400 Mol
See on map
Partners (11)
20122 Milano
See on map
2165 CK Lisserbroek
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
8093 Zurich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
8005 Zurich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
13083 875 Campinas Sp
See on map
116024 Dalian
See on map
SG8 6GB Shepreth
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
See on map
94720 Berkeley
See on map
28062 Cameri
See on map
1382 JL Weesp
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.